Tesamoralin 10MG

FDA-approved formulation, selective visceral belly fat targeting, proven clinical efficacy, standardized dosing. This 44-amino acid peptide with a trans-3-hexenoic acid modification selectively reduces visceral adipose tissue while preserving subcutaneous fat, making it unique among growth hormone therapies.